Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study.
Unexplained fatigue is often left untreated or treated with antidepressants. This randomized, placebo-controlled, single-blinded study evaluated the efficacy and tolerability of single-dose intravenous ferric carboxymaltose (FCM) in iron-deficient, premenopausal women with symptomatic, unexplained f...
Main Authors: | Bernard Favrat, Katharina Balck, Christian Breymann, Michael Hedenus, Thomas Keller, Anna Mezzacasa, Christoph Gasche |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3994001?pdf=render |
Similar Items
-
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
by: João Ricardo Friedrisch, et al.
Published: (2015-12-01) -
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
by: Melvin H. Seid, et al.
Published: (2017-01-01) -
Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia – reply
by: Rodolfo Delfini Cancado, et al.
Published: (2020-01-01) -
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
by: Sakiyeva Kanshaiym, et al.
Published: (2020-01-01) -
The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease
by: Pramoda Koduru, et al.
Published: (2016-01-01)